Comparison of live birth defects after luteal phase ovarian stimulation vs conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles

Capsule:
No evidence was found of detrimental effects of luteal-phase ovarian stimulation on live-born infants at birth. Infertility itself and multiple births pose risk factors for congenital malformation.

Authors:
Hong Chen, M.D., Yun Wang, M.D., Qifeng Lyu, Ph.D., Ai Ai, M.D., Yonglun Fu, M.D., Hui Tian, M.D., Renfei Cai, M.D., Qingqing Hong, M.D., Qiuju Chen, Ph.D., Zeev Shoham, M.D., Yanping Kuang, M.D.

Volume 103, Issue 5, Pages 1194-1201

Abstract:

Objective:
To assess live-birth defects after a luteal-phase ovarian-stimulation regimen (LPS) for in vitro fertilization (IVF) and vitrified embryo transfer (ET) cycles.

Design:
Retrospective cohort study.

Setting:
Tertiary-care academic medical center.

Patient(s):
Infants who were born between January 1, 2013 and May 1, 2014 from IVF with intracytoplasmic sperm injection (ICSI) treatments (n = 2,060) after either LPS (n = 587), the standard gonadotropin-releasing hormone–agonist (GnRH-a) short protocol (n = 1,257), or mild ovarian stimulation (n = 216).

Intervention(s):
The three ovarian-stimulation protocols described and assisted reproductive technology (ART) treatment (IVF or ICSI, and vitrified ET) in ordinary practice.

Main Outcome Measure(s):
The main measures were: gestational age, birth weight and length, multiple delivery, early neonatal mortality, and birth defects. Associations were assessed using logistic regression by adjusting for confounding factors.

Result(s):
The final sample included 2,060 live-born infants, corresponding to 1,622 frozen–thawed (FET) cycles, which led to: 587 live-born infants from LPS (458 FET cycles); 1,257 live-born infants from the short protocol (984 FET cycles); and 216 live-born infants from mild ovarian stimulation (180 FET cycles). Birth characteristics regarding gestational age, birth weight and length, multiple delivery, and early neonatal death were comparable in all groups. The incidence of live-birth defects among the LPS group (1.02%) and the short GnRH-a protocol group (0.64%) was slightly higher than in the mild ovarian-stimulation group (0.46%). However, none of these differences reached statistical significance. For congenital malformations, the risk significantly increased for the infertility-duration factor and multiple births; the adjusted odds ratios were 1.161 (95% confidence interval [CI]: 1.009–1.335) and 3.899 (95% CI: 1.179–12.896), respectively. No associations were found between congenital birth defects and various ovarian-stimulation regimens, maternal age, body mass index, parity, insemination method, or infant gender.

Conclusion(s):
To date, the data do not indicate an elevated rate of abnormality at birth after LPS, but further study with larger populations is needed to confirm these results. However, infertility itself poses a risk factor for congenital malformation. A higher likelihood of birth defects in multiple births may lead couples to favor elective, single ET; couples undertaking ART should be made aware of the known increased birth defects associated with a twin birth.

Translate »